Preparation method of eye patch for treating conjunctival hemorrhage

Abstract

The invention discloses a preparation method of an eye patch for treating conjunctival hemorrhage. The preparation method includes the steps that 1, ceramium kondoi Yendo and rhus chinensis Mill. are taken and smashed, water is added for decoction, and then filter liquor is retained for use; 2, thunbergia fragrans Roxb., kelp, dichocarpum auriculatum(Franch.)W.T.Wang et Hsiao, pleurotus ostreatus, pueraria seeds, water shield, common floweringquince fruits, botrychium virginianum and inula racemosa are taken, washed clean, aired, smashed, mixed and then soaked, water is added for decoction, ethyl alcohol is added after standing, centrifugation is carried out, supernatant liquor is taken, ethyl alcohol is recovered, and refined liquor is obtained; 3, the filter liquor obtained in the step 1 and the refined liquor obtained in the step 2 are mixed, vacuum concentration is carried out till the density is 1.3 g / cm<3>, sterilization is carried out, and after 5*6 cm sterile gauze is soaked, the end product eye patch is obtained. The eye patch is reasonable in composition, definite in treatment effect and capable of effectively treating subconjunctival hemorrhage.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicines, in particular to a preparation method of a conjunctival hemorrhage eye patch. Background technique [0002] Subconjunctival hemorrhage is mostly due to the rupture or significantly enhanced permeability of small subconjunctival blood vessels, and blood enters the subconjunctival tissue space. The bulbar conjunctiva is a thin layer of conjunctiva with a smooth surface and transparent texture, loosely connected with the eyeball fascia. The tissue around the bulbar conjunctiva is loose, and the extravascular pressure is low. Therefore, hemorrhage is prone to occur when the intravascular pressure increases or the blood vessels and blood factors are abnormal. Most of them are related to trauma, hemorrhagic conjunctivitis, arteriosclerosis, hypertension, diabetes, blood diseases, and increased vascular fragility. [0003] The treatment of the disease is currently mainly aimed at the prima...

AI Technical Summary

Problems solved by technology

[0004] However, patients do not have the ability to distinguish the pathogenesis of the disease based on syndrome differentiation and treatment. Therefore, there is an urgent need for a topical drug that can be widely used in patients with hemorrhagic diseases for internal and external bleeding, and patients do not need dialectical treatment, but can use it on their own.

Images